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Abstract
Background: In recent years, the world has seen a surge in Enterobacteriaceae resistant to broad-spectrum beta-
lactam antibiotics due to the production of extended-spectrum beta-lactamases (ESBLs) or plasmid-mediated AmpC
(pAmpC) enzymes. Data on the epidemiology of cephalosporin-resistant Enterobacteriaceae in Sub-Saharan Africa
are still limited.
Methods: Two hundred seventy-five non-repetitive stool samples were collected from Mozambican university
students of both sexes. Samples were cultured on MacConkey agar with and without ceftriaxone (1 mg/L) for
selection of third-generation cephalosporin-resistant isolates, which were subjected to antimicrobial susceptibility
testing by disc diffusion, characterization of resistance genes by PCR and ERIC-PCR analysis for strain clonality.
Results: Among the 275 students, 55 (20%) carried a total of 56 E. coli (n = 35) and Klebsiella spp. (n = 21) isolates
resistant to ceftriaxone and phenotypically positive for ESBL- and/or pAmpC-production. Forty-three percent of the
isolates (24/56) contained only ESBL genes, 11% (6/56) only pAmpC genes, and 36% (20/56) both ESBL and pAmpC
genes. The remaining six isolates were negative for the CTX-M/pAmpC genes included in the test panel. E. coli and
Klebsiella spp. combined demonstrated 70% resistance to tetracycline and co-trimoxazole, 63% to ceftazidime and 34%
to ciprofloxacin. In total, 89% of ESBL/pAmpC-positive isolates were defined as multi-resistant by being resistant to
three or more antibiotic classes. ERIC-PCR fingerprinting demonstrated low similarity among isolates. None of the
participants reported recent hospitalization and just 12.5% had taken antibiotics 3 months prior to the study.
Conclusion: This study demonstrated 20% colonization with multi-resistant E. coli and Klebsiella spp. among
Mozambican students with a diversity of ESBL and pAmpC genes. Colonization was not related to prior hospitalization
or antimicrobial consumption.
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Background
In recent years, the world has seen a surge in Enterobac-
teriaceae resistant to broad-spectrum beta-lactam antibi-
otics attributed to the production of extended-spectrum
beta-lactamases (ESBLs) and/or plasmid-mediated
AmpC (pAmpC) enzymes [1, 2]. ESBLs are, by the
classical definition, inhibited by clavulanic acid [3]
whereas pAmpC enzymes are not [4]. The plasmid loca-
tion of ESBL and pAmpC genes facilitates their spread
via horizontal gene transfer [5, 6].
Escherichia coli and Klebsiella pneumoniae are not
only constituents of the commensal gut flora but also
common opportunistic pathogens often implicated in
urinary tract and bloodstream infections [7, 8]. They
frequently harbor ESBL- and pAmpC-encoding genes.
Broad-spectrum beta-lactamase production is associated
with increased morbidity and mortality in both high-
and low/middle-income countries [9, 10].
Data on the epidemiology of ESBL- and pAmpC--
producing Enterobacteriaceae in Africa are still limited.
The majority of publications report on the prevalence of
ESBL-producing Enterobacteriaceae in clinical samples,
and there are only few studies on colonization [11, 12].
Furthermore, there is a predominance of reports from
Northern and Western Africa [13, 14] and only indi-
vidual studies from Eastern and Southern Africa [15–
17] (excluding South-Africa). The aim of this study
was to determine the prevalence of fecal colonization
with ESBL- and pAmpC-producing E. coli and Klebsiella
spp. among healthy university students in Maputo,
Mozambique, and to analyze the resistance phenotype,




A random sample of 275 university students of both
sexes living in three residences at the Eduardo
Mondlane University in Maputo, Mozambique, provided
non-repetitive stool specimens within a six-week period,
from January to February 2016 upon informed, voluntary
consent. Students with diarrheal disease were excluded
from the study. Participants provided information about
antibiotic use within 3 months and hospitalization within
6 months prior to the study. Stool samples were kept on
ice and transported to the laboratory for immediate
culture twice daily.
Identification and susceptibility testing
All samples were cultured on MacConkey agar with and
without ceftriaxone (1 mg/L) for selection of third-genera-
tion cephalosporin-resistant isolates. Lactose-positive
isolates growing on the 1 mg/L ceftriaxone agar were
identified to the species level using API20E (bioMérieux,
South Africa). A total of 56 E. coli (n = 35) and Klebsiella
spp. (n = 21) isolates were identified by this procedure.
Two isolates were recovered from the same sample. These
putative ESBL- and/or pAmpC-producers constituted the
study sample and were subjected to antimicrobial suscep-
tibility testing by disc diffusion to the following antibiotics:
cefoxitin, ceftazidime, ceftriaxone, imipenem, amikacin,
gentamicin, ciprofloxacin and co-trimoxazole. The results
were interpreted according to the CLSI breakpoints to
determine their susceptibility profile [18]. Multi-resistance
was defined as resistance to three or more antibiotic
classes. E. coli ATCC 25922 (wild-type) and K. pneumoniae
ATCC 700603 (ESBL positive) were used as negative
and positive quality control strains for antimicrobial
susceptibility testing and ESBL screening, respectively.
Phenotypic and genotypic characterization of beta-
lactamases
ESBL production was confirmed by double disc synergy
using ROSCO discs (Rosco Diagnostic, Taastrup,
Denmark) containing ceftazidime, ceftriaxone and
amoxicillin/clavulanic acid. pAmpC production was
determined using ROSCO discs containing cefotaxime,
cefotaxime+boronic acid, ceftazidime and ceftazidime
+boronic acid [18]. Isolates with reduced susceptibility
to carbapenems were subjected to the Carba NP test as
described previously [19]. E. coli ATCC 25922 and K.
pneumoniae ATCC 700603 were used as negative and
positive quality control strains, respectively.
For DNA extraction, 18–24 h colonies grown on
Muller Hinton agar were inoculated into Luria-Bertani
(LB) broth and incubated at 37 °C with shaking [20].
After 20 h of incubation, DNA was extracted using the
ZR Fungal/Bacterial DNA MiniPrep kit (Zymo Research,
Lithuania). PCR amplifications for detection of blaTEM,
blaSHV, blaCTX, blaCMY, blaDHA, blaFOX and blaMOX
(Table 1) were performed in a ThermalCycler T100™
(Bio-Rad, USA) with a final volume of 50 μL (25 μL of
Master mix, 15 μL of water, 4 μL of each primer with a
final concentration of 0.8 μM (Inqaba Biotechnology
Industries, South Africa) and 2 μL of template DNA),
with an initial denaturation temperature of 98 °C for
10 s, extension at 72 °C for 15 s and a final extension at
72 °C for 1 min. The annealing temperatures were as
follows: blaTEM 60 °C, blaSHV 56 °C, blaCTX 57 °C,
blaCMY 57 °C, and blaDHA, blaFOX and blaMOX 50 °C.
PCR products were loaded on a 1.5% (w/v) agarose gel
and visualized by UV transillumination (Bio-Rad Chemi-
Doc™MP System) after staining in 0.1 mg/mL Gel Red
for 15 min. A random sample of 19 CTX-M PCR
amplicons were sent to Inqaba Biotec (South Africa) for
DNA sequencing. TEM and SHV amplicons were not
sequenced.
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Genomic DNA isolation and ERIC-PCR analysis
Genomic DNA was isolated and purified using the
GeneJet Genomic DNA Purification Kit (Thermo
Scientific, USA). Antibiotic-susceptible E. coli ATCC
25922 and beta-lactam resistant SHV-18 K. pneumo-
niae ATCC 700603 were used as quality controls. The
total PCR reaction volume was 10 μL, which con-
tained 100 ng of template DNA, 50 pmol of each
primer, 2.8 μL nuclease-free water and 5 μL of
DreamTaq PCR Mastermix (2X) (Thermo Scientific).
The primers ERIC 1 and ERIC 2 [21] were used. PCR
conditions were as follows: 94 °C for 3 min, 30 cycles
of 30 s of denaturation at 94 °C, 1 min of annealing
at 50 °C, 8 min of extension at 65 °C, and a final
elongation of 16 min at 65 °C, in an Applied Biosys-
tems 2720 thermal cycler. The ERIC-PCR products
were loaded onto 1% (w/v) agarose gels and subjected
to electrophoresis at 80 V using 1 × TAE buffer. Amp-
lification products were visualized by UV transillu-
mination (Syngene, UK) after staining in 0.1 mg/mL
ethidium bromide for 15 min. Genotypic variation
was analyzed using the Gel Compare II version 6.0
software package (Applied Maths, Belgium) by
Jacquard index and Unweighted Pair Group Method
with Arithmetic Mean (UPGMA) cluster analysis to
produce a dendrogram.
Statistical analyses
Groups were compared by the Fischer Exact Test
using the Epi Info StatCalc software version 7.2.2.6
(CDC, Atlanta, USA) with statistical significance
defined as p < 0.05.
Results
Setting and samples
Among the 275 samples collected in the study, 159
(58%) were retrieved from male students and 116 (42%)
from females in an age range from 19 to 32 years old.
The students lived in separate blocks and/or floors for
male and female students. Each floor had one kitchen
where students could prepare their own food. There
were students from different courses including, but not
limited to Engineering, Medicine, Political Science,
Biology and Sociology. All participants declared a history
of non-hospitalization 6 months prior to the study and
87.5% had not consumed any antibiotics for at least
3 months.
Frequency of E. coli and Klebsiella spp. ESBL colonization
In 55 of 275 non-repetitive stool samples 35 E. coli and
21 Klebsiella spp. grew on MacConkey agar containing
1 mg/L ceftriaxone, with one sample providing two
isolates. The overall prevalence of ceftriaxone-resistant
E. coli and Klebsiella spp. colonization was thus 20%
(55/275). There was no statistically significant difference
in the rate of colonization between females (n = 28, 24%)
and males (n = 28, 17%). All samples displayed growth
on the ceftriaxone-free growth control agar.
Phenotypic analyses of antimicrobial susceptibility
All the 56 E. coli (n = 35) and Klebsiella spp. (n = 21)
isolates were phenotypically confirmed as ESBL and/or
pAmpC producers and showed high rates of resistance
to tetracycline and co-trimoxazole (70%), ceftazidime
(63%), cefoxitin (41%), and ciprofloxacin (34%). Two
isolates displayed carbapenem zone diameters below the
screening breakpoint for carbapenemase production, but
were categorized as susceptible by the clinical break-
point. They were subsequently negative in the Carba NP
test and there were thus no carbapenemase producers
(Table 2). Eighty-eight percent of the isolates were
defined as multi-resistant. Antimicrobial susceptibility
results are presented in the Additional file 1: Table S1.
ESBL gene identification by PCR and sequencing
The PCR results for CTX-M and pAmpC genes are
summarized in Table 3. Among 56 isolates, 41% were
positive for at least two genes, 32% were positive for at
least three, and 23% were positive for at least four genes.
Forty-three percent (24/56) of the isolates contained
only CTX-M, 11% (6/56) only pAmpC, and 36% (20/56)
both CTX-M and pAmpC sequences. Six isolates (11%)
were negative for CTX-M and pAmpC genes but con-
tained TEM and/or SHV sequences (data not shown).
However, as these amplicons were not sequenced it can-
not be concluded that they encode broad-spectrum
beta-lactamases and the basis for ceftriaxone resistance
Table 1 Primers used for amplification of ESBL genes
Target
enzyme
Primers Sequence (5′ to 3′) Annealing
temperature (ref)
TEM-1 TEMMF AAA ATT CTT GAA GAC G 60 °C [29]
TEMMR TTA CCA ATG CTT AAT CA
SHV SHVMF TTA ACT CCC TGT TAG CCA 56 °C [29]
SHVMR GAT TTG CTG ATT TCG CCC
CTX-1 CTXMF GGT TAA AAA ATC ACT GCG TC 57 °C [27]
CTXMR TTG GTG ACG ATT TTA GCC GC
CMY CMYMF GAT TCC TTG GAC TCT TCA G 57 °C [28]
CMYMR TAA AAC CAG GTT CCC AGA TAG C
FOX FOXMF CAC CAC GAG AAT AAC CAT 57 °C [28]
FOXMR ATG TGG ACG CCT TGA ACT
DHA DHAMF AAC TTT CAC AGG TGT GCT GGG T 57 °C [28]
DHAMR CCG TAC GCA TAC TGG CTT TGC
MOX MOXMF GCT GCT CAA GGA GCA CAG GAT 50 °C [28]
MOXMR CAC ATT GAC ATA GGT GTG GTG C
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in these isolates was consequently not determined. A
total of 67 CTX-M/pAmpC genes were found in the 35
E. coli isolates and 41 in the 21 Klebsiella spp. isolates.
CTX-M was the most common gene detected in both E.
coli (n = 25) and Klebsiella spp. (n = 16) followed by
DHA (n = 15 in E. coli and n = 9 in Klebsiella spp.).
DNA sequencing of 19 randomly selected CTX-M
amplicons from E. coli (n = 13) and Klebsiella spp. (n = 6)
revealed a predominance of blaCTX-M-15 (n = 14) and occa-
sional detection of blaCTX-M-55 (n = 3), blaCTX-M-3 (n = 1)
and blaCTX-M-186 (n = 1). A full list of CTX-M and pAmpC
gene content in individual strains is presented in the
Additional file 1: Table S1.
ERIC-PCR results for E. coli
Distinct ERIC-PCR profiles were obtained for the 35 E.
coli isolates (Fig. 1). The absence or presence of a band
was noted in determining variation among isolates, and
banding patterns comprised between 2 and 14 individual
bands. Fragments of different molecular weights were
observed in the ERIC-PCR fingerprints, ranging from
0.5–20 kb (Fig. 1). Amplification of different intensities
was observed and visual analysis of the ERIC profiles
included primary, secondary and tertiary amplification
(Fig. 1). Primary amplification products refer to those
products of high intensity, which appear extremely
bright on the gels. Secondary amplification products are
those products that are not as bright as the primary
amplification products but more intense that the tertiary
amplification products, while the tertiary amplification
products are the minor amplification products of low
intensity [22]. All isolates were typeable using this
fingerprinting technique and band profiles were repro-
ducibly obtained under similar experimental conditions
on repeat amplification.
The ERIC-PCR profiles allowed differentiation of the
35 E. coli isolates into 24 ERIC-PCR types which were
grouped into 15 clusters (A-O), each of which were
futher sub-divided into multiple sub-clusters (Fig. 1).
CTX-M and pAmpC genes were amplified from isolates
in different clusters. Isolates with similar profiles demon-
strated varying beta-lactamase gene content.
ERIC-PCR results for Klebsiella spp.
Twenty-one Klebsiella spp. isolates were subjected to
ERIC-PCR analysis in comparison to the SHV-18 con-
taining K. pneumoniae ATCC 700603. Distinct profiles
were obtained for all isolates tested using ERIC-PCR
fingerprinting (Fig. 2). Banding patterns comprised
between 2 and 16 individual bands. Fragments of differ-
ent molecular weights were observed in the ERIC-PCR
fingerprints, ranging from 0.5–20 kb (Fig. 2).
The ERIC-PCR profiles allowed differentiation of the 21
isolates into 17 ERIC-PCR types which were grouped into
12 clusters (A-L), each of which were further sub-divided
into multiple sub-clusters (Fig. 2). CTX-M and pAmpC
genes were identified in isolates from different clusters,
predominantly clusters B-G. Isolates with similar profiles
demonstrated varying beta-lactamase gene content.
Discussion
Antibiotic-resistant bacteria are an escalating cause of
infections in Mozambique and worldwide, but informa-
tion regarding the molecular epidemiology of ESBL- and
pAmpC-producing Enterobacteriaceae in the country
remains scarce. To our knowledge, this is the first study
reporting on gastrointestinal colonization with ESBL-
and pAmpC-producing Enterobacteriaceae among
university students in Mozambique.
We systematically collected samples from healthy stu-
dents to determine the prevalence of colonization by E.
coli and Klebsiella spp. carrying ESBL and/or pAmpC,
as well as their antibiotic susceptibility. In total, 20% of
students (55/275) were colonized with ESBL and/or
pAmpC positive E. coli and Klebsiella spp. Similar re-
sults were found in a study conducted in pre-school
children attending childcare facilities in the Lao People’s
Democratic Republic where the ESBL prevalence was
23% [23] while the prevalence amongst patients in inten-
sive care in Korea was 28.2% with a higher frequency in
E. coli (78%) compared with Klebsiella spp. (18%) [24]. A
study recently conducted in Madagascar [18] in commu-
nity settings demonstrated lower rates of colonization by
ESBL-positive Gram-negative bacilli compared to this
Table 2 Antimicrobial resistance (%) of ESBL-producing E. coli
and Klebsiella spp









Table 3 Distribution of ESBL enzymes according to species
ESBL enzymes E. coli (n = 35) Klebsiella spp. (n = 21) Total
CTX-M 28 16 44
DHA 15 9 24
MOX 10 7 17
FOX 7 5 12
CMY 7 4 11
TOTAL 104 57 161
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study, despite the fact that more species were included
in addition to E. coli and Klebsiella spp. The present
study showed a higher prevalence of ESBL and pAmpC
colonization compared to a study conducted in rural
communities in France where the frequency of ESBL
colonization was 5.3% [25]. This large difference may be
attributed to poorly controlled antibiotic consumption
and sub-optimal hygiene conditions in developing coun-
tries [26]. In Mozambique, antibiotic therapy is mostly
empirical because of scarce diagnostic microbiology
facilities [27]. We found 36% co-existence of ESBL and
pAmpC beta-lactamase genes which is high compared to
reports from clinical isolates in Turkey (13.9%) [28].
The CTX-M positive isolates carried different genotypes;
blaCTX-M-15 (n = 14), blaCTX-M-55 (n = 3), blaCTX-M-186
(n = 1) and blaCTX-M-3 (n = 1). These results are similar to
findings in a study conducted in Tanzania [29] that found
blaCTX-M-15 genes in 95% of the carriers, but differ from a
study in Kenya [30] which demonstrated only 29% of the
isolates carrying blaCTX-M-15 and 4% carrying blaCTX-M-3.
Fig. 1 Dendrogram representing the genetic relatedness and cluster analysis of 35 E. coli strains isolated from stool samples of university students, based on
ERIC-PCR fingerprinting patterns using Jacquard index and UPGMA algorithm. The scale at the top represents percentage similarity to E. coli ATCC 25922
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No isolates harbored blaCTX-M-55 or blaCTX-M-186 in the
Kenyan study. blaCTX-M-55 is endemic in many Asian
countries, and the detection of this variant in Mozambique
may reflect travel and trade with this part of the world [31].
In this study of healthy students, none of the partici-
pants had a history of hospitalization 6 months prior to
the study, and 87.5% had not consumed any antibiotics at
least 3 months prior to the study. This suggests that the
high antibiotic resistance rates are not related to antibiotic
consumption or hospitalization, and may indicate that the
E. coli and Klebsiella ESBL- and pAmpC-producers
isolated in this study were acquired in the community. In
the university residences there is a mixture of students
from different courses including medicine and health
sciences, but the study was not powered to analyse differ-
ences between student groups (data not shown). ESBL-
and/or pAmpC-colonized students working in health
institutions may constitute a reservoir for further spread
of multi-resistant microorganisms among patients.
To control the rapid dissemination of resistant Entero-
bacteriaceae among students and, consequently, the gen-
eral population, it is necessary to educate students about
the importance of personal hygiene. It is also necessary
to perform further studies to determine the prevalence
of colonization in different groups of the population.
The prevalence in different studies may vary depending
on socio-economic status of individuals involved [32],
and this makes it difficult to estimate the prevalence in
the general population in Mozambique. One may
suppose that transmission between students is facilitated
because of the conditions they live under with many
individuals sharing the same bathroom and kitchen.
However, the diversity of strains demonstrated using
ERIC-PCR indicates that there is at present no wide-
spread clonal outbreak, although there could be horizon-
tal transfer of plasmids or other mobile genetic
elements. One may speculate that students are exposed
to ESBL and/or pAmpC isolates from some external
source like dissemination in the food supply. Very little
is known about the occurrence of ESBL and pAmpC
strains in the food supply in Mozambique, but it is
reported from other countries that ESBL and pAmpC E.
coli and Klebsiella spp. may disseminate in food animals
and environmental sources [33–37].
Conclusions
This study demonstrated a 20% prevalence of colonization
by multi-drug resistant, non-clonally-related ESBL- and/
or pAmpC positive E. coli and Klebsiella spp. isolates
among male and female university students in
Fig. 2 Dendrogram representing the genetic relatedness and cluster analysis of 21 Klebsiella spp. strains isolated from stool samples of university
students, based on ERIC-PCR fingerprinting patterns using Jacquard index and UPGMA algorithm. The scale at the top represents percentage
similarity to Klebsiella pneumoniae ATCC 700603
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Mozambique. Colonization of ESBL/pAmpC in the popu-
lation of study was not related to prior antimicrobial
consumption or hospitalization. Similar studies should be
done to further explore the epidemiology of multi-drug
resistant Enterobacteriaceae in the population as a whole.
Additional file
Additional file 1: Table S1. Resistance genes identified and sensitivity
results of E. coli and Klebsiella spp. (DOCX 38 kb)
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